NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
McDonagh M, Skelly AC, Hermesch A, et al. Cervical Ripening in the Outpatient Setting [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. (Comparative Effectiveness Review, No. 238.)
- 1.
- American College of Obstetrics and Gynecology. Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. 2018. https://www
.acog.org /Clinical-Guidance-and-Publications /Practice-Advisories /Practice-Advisory-Clinical-guidance-for-integration-of-the-findings-of-The-ARRIVE-Trial?IsMobileSet =false. Accessed December 18, 2019. - 2.
- Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries. Obstet Gynecol. 2019 Feb;133(2):e151–e5. doi: 10.1097/AOG.0000000000003083. PMID: 30681545. [PubMed: 30681545] [CrossRef]
- 3.
- American College of Obstetricians Gynecologists. Practice bulletin no. 146: Management of late-term and postterm pregnancies. Obstet Gynecol. 2014 Aug;124(2 Pt 1):390–6. doi: 10.1097/01.AOG.0000452744.06088.48. PMID: 25050770. [PubMed: 25050770] [CrossRef]
- 4.
- World Health Organization. WHO recommendations for induction of labour. Geneva: World Health Organization; 2011. https://apps
.who.int /iris/handle/10665/44531. Accessed December 18, 2019. [PubMed: 23586118] - 5.
- Grobman WA, Rice MM, Reddy UM, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018 Aug 09;379(6):513–23. doi: 10.1056/NEJMoa1800566. PMID: 30089070. [PMC free article: PMC6186292] [PubMed: 30089070] [CrossRef]
- 6.
- Martin JA, Hamilton BE, Osterman MJK, et al. Births: Final Data for 2017. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2018 Nov;67(8):1–50. PMID: 30707672. [PubMed: 30707672]
- 7.
- Pierce S, Bakker R, Myers DA, et al. Clinical Insights for Cervical Ripening and Labor Induction Using Prostaglandins. AJP Reports. 2018;8(4):e307–e14. doi: 10.1055/s-0038-1675351. [PMC free article: PMC6205862] [PubMed: 30377555] [CrossRef]
- 8.
- Ananth CV, Wilcox AJ, Gyamfi-Bannerman C. Obstetrical interventions for term first deliveries in the US. Paediatr Perinat Epidemiol. 2013 Sep;27(5):442–51. doi: 10.1111/ppe.12068. PMID: 23930780. [PMC free article: PMC3963489] [PubMed: 23930780] [CrossRef]
- 9.
- Lydon-Rochelle MT, Cardenas V, Nelson JC, et al. Induction of labor in the absence of standard medical indications: incidence and correlates. Med Care. 2007 Jun;45(6):505–12. PMID: 17515777. [PubMed: 17515777]
- 10.
- Bernardes TP, Broekhuijsen K, Koopmans CM, et al. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials. BJOG. 2016 Aug;123(9):1501–8. doi: 10.1111/1471-0528.14028. PMID: 27173131. [PubMed: 27173131] [CrossRef]
- 11.
- Bartha JL, Romero-Carmona R, Martinez-Del-Fresno P, et al. Bishop score and transvaginal ultrasound for preinduction cervical assessment: a randomized clinical trial. Ultrasound Obstet Gynecol. 2005 Feb;25(2):155–9. PMID: 15660437. [PubMed: 15660437]
- 12.
- Carlson NS, Neal JL, Tilden EL, et al. Influence of midwifery presence in United States centers on labor care and outcomes of low-risk parous women: A Consortium on Safe Labor study. Birth. 2019;46(3):487–99. doi: 10.1111/birt.12405. PMID: 30414200. [PMC free article: PMC6509022] [PubMed: 30414200] [CrossRef]
- 13.
- Neal JL, Carlson NS, Phillippi JC, et al. Midwifery presence in United States medical centers and labor care and birth outcomes among low-risk nulliparous women: A Consortium on Safe Labor study. Birth. 2018 Nov 11 doi: 10.1111/birt.12407. PMID: 30417436. [PMC free article: PMC6511333] [PubMed: 30417436] [CrossRef]
- 14.
- ACOG Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386–97. doi: 10.1097/AOG.0b013e3181b48ef5. PMID: 19623003. [PubMed: 19623003] [CrossRef]
- 15.
- Vogel JP, Osoti AO, Kelly AJ, et al. Pharmacological and mechanical interventions for labour induction in outpatient settings. Cochrane Database Syst Rev. 2017;9:CD007701. doi: 10.1002/14651858.CD007701.pub3. PMID: 28901007. [PMC free article: PMC6483740] [PubMed: 28901007] [CrossRef]
- 16.
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 Jan 1;4(1):1. doi: 10.1186/2046-4053-4-1. PMID: 25554246. [PMC free article: PMC4320440] [PubMed: 25554246] [CrossRef]
- 17.
- Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ Publication No. 10(14)-EHC063-EF. AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research Quality; January 2014. https:
//effectivehealthcare .ahrq.gov/topics /cer-methods-guide/overview PMID: 21433403. - 18.
- Viswanathan M, Patnode CD, Berkman ND, et al. Assessing the risk of bias in systematic reviews of health care interventions. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2017. PMID: 30125066.
- 19.
- Furlan AD, Malmivaara A, Chou R, et al. 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine. 2015;40(21):1660–73. PMID: 26208232. [PubMed: 26208232]
- 20.
- Higgins J, Savović J, Page M, et al. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions version 6 (updated July 2019). Cochrane; 2019.
- 21.
- US Preventive Services Task Force Procedure Manual. Rockville, MD: Agency for Healthcare Research and Quality; October 2018. https://www
.uspreventiveservicestaskforce .org/Page/Name/procedure-manual. - 22.
- Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med. 1996 Mar 30;15(6):619–29. doi: 10.1002/(sici)1097-0258(19960330)15:6<619::Aid-sim188>3.0.Co;2-a. PMID: 8731004. [PubMed: 8731004] [CrossRef]
- 23.
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–58. doi: 10.1002/sim.1186. PMID: 12111919. [PubMed: 12111919] [CrossRef]
- 24.
- Berkman ND, Lohr KN, Ansari MT, et al. Grading the strength of a body of evidence when assessing health care interventions: an EPC update. J Clin Epidemiol. 2015 Nov;68(11):1312–24. doi: 10.1016/j.jclinepi.2014.11.023. PMID: 25721570. [PubMed: 25721570] [CrossRef]
- 25.
- Awartani KA, Turnell RW, Olatunbosun OA. A prospective study of induction of labor with prostaglandin vaginal gel: ambulatory versus in-patient administration. Clin Exp Obstet Gynecol. 1999;26(3–4):162–5. PMID: 10668144. [PubMed: 10668144]
- 26.
- Beckmann M, Gibbons K, Flenady V, et al. Induction of labour using prostaglandin E2 as an inpatient versus balloon catheter as an outpatient: a multicentre randomised controlled trial. BJOG. 2019 Nov 29;29:29. doi: 10.1111/1471-0528.16030. PMID: 31785056. [PubMed: 31785056] [CrossRef]
- 27.
- Biem SR, Turnell RW, Olatunbosun O, et al. A randomized controlled trial of outpatient versus inpatient labour induction with vaginal controlled-release prostaglandin-E2: effectiveness and satisfaction. J Obstet Gynaecol Can. 2003 Jan;25(1):23–31. doi: 10.1016/s1701-2163(16)31079-9. PMID: 12548322. [PubMed: 12548322] [CrossRef]
- 28.
- Buttino LT, Jr., Garite TJ. Intracervical prostaglandin in postdate pregnancy. A randomized trial. J Reprod Med. 1990 Feb;35(2):155–8. PMID: 2406438. [PubMed: 2406438]
- 29.
- Chang DW, Velazquez MD, Colyer M, et al. Vaginal misoprostol for cervical ripening at term: comparison of outpatient vs. inpatient administration. J Reprod Med. 2005 Oct;50(10):735–9. PMID: 16320553. [PubMed: 16320553]
- 30.
- Cundiff GW, Simpson ML, Koenig N, et al. Observational study of neonatal safety for outpatient labour induction priming with dinoprostone vaginal insert. J Obstet Gynaecol Can. 2017 May;39(5):354–60. doi: 10.1016/j.jogc.2017.01.003. PMID: 28363606. [PubMed: 28363606] [CrossRef]
- 31.
- Doany W, McCarty J. Outpatient management of the uncomplicated postdate pregnancy with intravaginal prostaglandin E2 gel and membrane stripping. J Matern Fetal Med. 1997 Mar–Apr;6(2):71–8. doi: 10.1002/(SICI)1520-6661(199703/04)6:2<71::AID-MFM2>3.0.CO;2-M. PMID: 9086420. [PubMed: 9086420] [CrossRef]
- 32.
- Farmer KC, Schwartz WJ, 3rd, Rayburn WF, et al. A cost-minimization analysis of intracervical prostaglandin E2 for cervical ripening in an outpatient versus inpatient setting. Clin Ther. 1996 Jul–Aug;18(4):747–56; discussion 02. doi: 10.1016/s0149-2918(96)80224-4. PMID: 8879901. [PubMed: 8879901] [CrossRef]
- 33.
- Gaffaney CA, Saul LL, Rumney PJ, et al. Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. Am J Perinatol. 2009 Oct;26(9):673–7. doi: 10.1055/s-0029-1220790. PMID: 19404900. [PubMed: 19404900] [CrossRef]
- 34.
- Henry A, Madan A, Reid R, et al. Outpatient foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. BMC Pregnancy Childbirth. 2013 Jan 29;13:25. doi: 10.1186/1471-2393-13-25. PMID: 23356673. [PMC free article: PMC3564932] [PubMed: 23356673] [CrossRef]
- 35.
- Herabutya Y, P OP. A comparison of oral and intracervical prostaglandin E2 for ripening of the unfavourable cervix prior to induction of labour. J Med Assoc Thai. 1988 May;71(5):269–73. PMID: 3165111. [PubMed: 3165111]
- 36.
- Howard K, Gerard K, Adelson P, et al. Women’s preferences for inpatient and outpatient priming for labour induction: a discrete choice experiment. BMC Health Serv Res. 2014 Jul 30;14:330. doi: 10.1186/1472-6963-14-330. PMID: 25073486. [PMC free article: PMC4128401] [PubMed: 25073486] [CrossRef]
- 37.
- Incerpi MH, Fassett MJ, Kjos SL, et al. Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol. 2001 Oct;185(4):916–9. doi: 10.1067/mob.2001.117306. PMID: 11641678. [PubMed: 11641678] [CrossRef]
- 38.
- Kipikasa JH, Adair CD, Williamson J, et al. Use of misoprostol on an outpatient basis for postdate pregnancy. Int J Gynaecol Obstet. 2005 Feb;88(2):108–11. doi: 10.1016/j.ijgo.2004.10.006. PMID: 15694083. [PubMed: 15694083] [CrossRef]
- 39.
- Kruit H, Heikinheimo O, Ulander VM, et al. Foley catheter induction of labor as an outpatient procedure. J Perinatol. 2016 Aug;36(8):618–22. doi: 10.1038/jp.2016.62. PMID: 27078202. [PubMed: 27078202] [CrossRef]
- 40.
- Kuper SG, Jauk VC, George DM, et al. Outpatient foley catheter for induction of labor in parous women: a randomized controlled trial. Obstet Gynecol. 2018 Jul;132(1):94–101. doi: 10.1097/AOG.0000000000002678. PMID: 29889751. [PubMed: 29889751] [CrossRef]
- 41.
- Larmon JE, Magann EF, Dickerson GA, et al. Outpatient cervical ripening with prostaglandin E2 and estradiol. J Matern Fetal Neonatal Med. 2002 Feb;11(2):113–7. doi: 10.1080/jmf.11.2.113.117. PMID: 12375540. [PubMed: 12375540] [CrossRef]
- 42.
- Lien JM, Morgan MA, Garite TJ, et al. Antepartum cervical ripening: applying prostaglandin E2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. Am J Obstet Gynecol. 1998 Aug;179(2):453–8. doi: 10.1016/s0002-9378(98)70378-3. PMID: 9731852. [PubMed: 9731852] [CrossRef]
- 43.
- Magann EF, Chauhan SP, McNamara MF, et al. Membrane sweeping versus dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with an unfavorable cervix. J Perinatol. 1999 Mar;19(2):88–91. doi: 10.1038/sj.jp.7200133. PMID: 10642965. [PubMed: 10642965] [CrossRef]
- 44.
- Magann EF, Chauhan SP, Nevils BG, et al. Management of pregnancies beyond forty-one weeks’ gestation with an unfavorable cervix. Am J Obstet Gynecol. 1998 Jun;178(6):1279–87. doi: 10.1016/s0002-9378(98)70334-5. PMID: 9662313. [PubMed: 9662313] [CrossRef]
- 45.
- McGee TM, Gidaszewski B, Khajehei M, et al. Foley catheter silicone versus latex for term outpatient induction of labour: a randomised trial. Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):235–42. doi: 10.1111/ajo.12828. PMID: 29943804. [PubMed: 29943804] [CrossRef]
- 46.
- McKenna DS, Costa SW, Samuels P. Prostaglandin E2 cervical ripening without subsequent induction of labor. Obstet Gynecol. 1999 Jul;94(1):11–4. doi: 10.1016/s0029-7844(99)00244-6. PMID: 10389710. [PubMed: 10389710] [CrossRef]
- 47.
- McKenna DS, Duke JM. Effectiveness and infectious morbidity of outpatient cervical ripening with a foley catheter. J Reprod Med. 2004a Jan;49(1):28–32. PMID: 14976792. [PubMed: 14976792]
- 48.
- McKenna DS, Ester JB, Proffitt M, et al. Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. Obstet Gynecol. 2004b Sep;104(3):579–84. doi: 10.1097/01.AOG.0000136479.72777.56. PMID: 15339772. [PubMed: 15339772] [CrossRef]
- 49.
- Meyer M, Pflum J, Howard D. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstet Gynecol. 2005 Mar;105(3):466–72. doi: 10.1097/01.AOG.0000152341.31873.d9. PMID: 15738009. [PubMed: 15738009] [CrossRef]
- 50.
- Oboro VO, Tabowei TO. Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post-term pregnancy. Acta Obstet Gynecol Scand. 2005 Jul;84(7):628–31. doi: 10.1111/j.0001-6349.2005.00655.x. PMID: 15954870. [PubMed: 15954870] [CrossRef]
- 51.
- Ohel G, Rahav D, Rothbart H, et al. Randomised trial of outpatient induction of labor with vaginal PGE2 at 40–41 weeks of gestation versus expectant management. Arch Gynecol Obstet. 1996;258(3):109–12. doi: 10.1007/s004040050110. PMID: 8781697. [PubMed: 8781697] [CrossRef]
- 52.
- Policiano C, Pimenta M, Martins D, et al. Outpatient versus inpatient cervix priming with foley catheter: a randomized trial. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:1–6. doi: 10.1016/j.ejogrb.2016.11.026. PMID: 27923165. [PubMed: 27923165] [CrossRef]
- 53.
- PonMalar J, Benjamin SJ, Abraham A, et al. Randomized double-blind placebo controlled study of preinduction cervical priming with 25 micro g of misoprostol in the outpatient setting to prevent formal induction of labour. Arch Gynecol Obstet. 2017 Jan;295(1):33–8. doi: 10.1007/s00404-016-4173-z. PMID: 27566696. [PubMed: 27566696] [CrossRef]
- 54.
- Rayburn WF, Gittens LN, Lucas MJ, et al. Weekly administration of prostaglandin E2 gel compared with expectant management in women with previous cesareans. Prepidil gel study group. Obstet Gynecol. 1999 Aug;94(2):250–4. doi: 10.1016/s0029-7844(99)00300-2. PMID: 10432137. [PubMed: 10432137] [CrossRef]
- 55.
- Salvador SC, Lynn Simpson M, Cundiff GW. Dinoprostone vaginal insert for labour induction: a comparison of outpatient and inpatient settings. J Obstet Gynaecol Can. 2009 Nov;31(11):1028–34. doi: 10.1016/S1701-2163(16)34347-X. PMID: 20175341. [PubMed: 20175341] [CrossRef]
- 56.
- Sawai SK, O’Brien WF, Mastrogiannis DS, et al. Patient-administered outpatient intravaginal prostaglandin E2 suppositories in post-date pregnancies: a double-blind, randomized, placebo-controlled study. Obstet Gynecol. 1994 Nov;84(5):807–10. PMID: 7936516. [PubMed: 7936516]
- 57.
- Sawai SK, Williams MC, O’Brien WF, et al. Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Obstet Gynecol. 1991 Jul;78(1):19–23. PMID: 2047061. [PubMed: 2047061]
- 58.
- Sciscione AC, Muench M, Pollock M, et al. Transcervical foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001 Nov;98(5 Pt 1):751–6. doi: 10.1016/s0029-7844(01)01579-4. PMID: 11704164. [PubMed: 11704164] [CrossRef]
- 59.
- Smith CV, Miller A, Livezey GT. Double-blind comparison of 2.5 and 5.0 mg of prostaglandin E2 gel for preinduction cervical ripening. J Reprod Med. 1996 Oct;41(10):745–8. PMID: 8913976. [PubMed: 8913976]
- 60.
- Stitely ML, Browning J, Fowler M, et al. Outpatient cervical ripening with intravaginal misoprostol. Obstet Gynecol. 2000 Nov;96(5 Pt 1):684–8. doi: 10.1016/s0029-7844(00)01034-6. PMID: 11042301. [PubMed: 11042301] [CrossRef]
- 61.
- Stock SJ, Taylor R, Mairs R, et al. Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies. Obstet Gynecol. 2014 Aug;124(2 Pt 1):354–60. doi: 10.1097/AOG.0000000000000394. PMID: 25004351. [PubMed: 25004351] [CrossRef]
- 62.
- Turnbull D, Adelson P, Oster C, et al. Psychosocial outcomes of a randomized controlled trial of outpatient cervical priming for induction of labor. Birth. 2013a Jun;40(2):75–80. doi: 10.1111/birt.12035. PMID: 24635460. [PubMed: 24635460] [CrossRef]
- 63.
- Turnbull D, Adelson P, Oster C, et al. The impact of outpatient priming for induction of labour on midwives’ work demand, work autonomy and satisfaction. Women Birth. 2013b Sep;26(3):207–12. doi: 10.1016/j.wombi.2013.03.001. PMID: 23561927. [PubMed: 23561927] [CrossRef]
- 64.
- Upadhyaya NB, Childs KD, Neiger R, et al. Ambulatory cervical ripening in term pregnancy. J Reprod Med. 1999 Apr;44(4):363–6. PMID: 10319307. [PubMed: 10319307]
- 65.
- Wilkinson C, Adelson P, Turnbull D. A comparison of inpatient with outpatient balloon catheter cervical ripening: a pilot randomized controlled trial. BMC Pregnancy Childbirth. 2015b May 28;15:126. doi: 10.1186/s12884-015-0550-z. PMID: 26018581. [PMC free article: PMC4450858] [PubMed: 26018581] [CrossRef]
- 66.
- Wilkinson C, Bryce R, Adelson P, et al. A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E2 (OPRA study). BJOG. 2015a Jan;122(1):94–104. doi: 10.1111/1471-0528.12846. PMID: 24824157. [PubMed: 24824157] [CrossRef]
- 67.
- Blair R, Harvey MA, Pudwell J, et al. Retrospective Comparison of PGE2 Vaginal Insert and Foley Catheter for Outpatient Cervical Ripening. J Obstet Gynaecol Can. 2020 May 29;29:29. doi: 10.1016/j.jogc.2020.02.112. PMID: 32482470. [PubMed: 32482470] [CrossRef]
- 68.
- Clarke P, Round N, Blythe S. Development of a home induction of labour framework. Br J Midwifery. 2017;25(1):34–40. doi: 10.12968/bjom.2017.25.1.34. PMID: 120705887. . [CrossRef]
- 69.
- Heimstad R, Romundstad PR, Hyett J, et al. Women’s experiences and attitudes towards expectant management and induction of labor for post-term pregnancy. Acta Obstet Gynecol Scand. 2007a;86(8):950–6. doi: 10.1080/00016340701416929. PMID: 17653880. [PubMed: 17653880] [CrossRef]
- 70.
- Levine LD, Sciscione AC. Foley catheter for outpatient cervical ripening: review of the evidence and a proposed model of care. Am J Perinatol. 2019 Dec;36(14):1528–32. doi: 10.1055/s-0038-1677473. PMID: 30674049. [PubMed: 30674049] [CrossRef]
- 71.
- Neale E, Pachulski A, Whiterod S, et al. Outpatient cervical ripening prior to induction of labour. J Obstet Gynaecol. 2002 Nov;22(6):634–5. doi: 10.1080/0144361021000020411. PMID: 12554251. [PubMed: 12554251] [CrossRef]
- 72.
- O’Brien E, Rauf Z, Alfirevic Z, et al. Women’s experiences of outpatient induction of labour with remote continuous monitoring. Midwifery. 2013 Apr;29(4):325–31. doi: 10.1016/j.midw.2012.01.014. PMID: 23159160. [PubMed: 23159160] [CrossRef]
- 73.
- Oster C, Adelson PL, Wilkinson C, et al. Inpatient versus outpatient cervical priming for induction of labour: therapeutic landscapes and women’s preferences. Health Place. 2011 Jan;17(1):379–85. doi: 10.1016/j.healthplace.2010.12.001. PMID: 21185217. [PubMed: 21185217] [CrossRef]
- 74.
- Sutton C, Harding J, Griffin C. Patient attitudes towards outpatient cervical ripening prior to induction of labour at an Australian tertiary hospital. J Obstet Gynaecol. 2016 Oct;36(7):921–8. doi: 10.1080/01443615.2016.1174826. PMID: 27188719. [PubMed: 27188719] [CrossRef]
- 75.
- Taylor SJ, Armour CL. Measurement of consumer preference for treatments used to induce labour: a willingness-to-pay approach. Health Expect. 2000;3(3):203–16. doi: 10.1046/j.1369-6513.2000.00098.x. [PMC free article: PMC5080968] [PubMed: 11281930] [CrossRef]
- 76.
- Menard MK, Main EK, Currigan SM. Executive summary of the reVITALize initiative: standardizing obstetric data definitions. Obstet Gynecol. 2014 Jul;124(1):150–3. doi: 10.1097/aog.0000000000000322. PMID: 24901267. [PubMed: 24901267] [CrossRef]
- 77.
- Betrán AP, Ye J, Moller A-B, et al. The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990–2014. PLoS ONE. 2016;11(2):e0148343–e. doi: 10.1371/journal.pone.0148343. PMID: 26849801. [PMC free article: PMC4743929] [PubMed: 26849801] [CrossRef]
- References - Cervical Ripening in the Outpatient SettingReferences - Cervical Ripening in the Outpatient Setting
- Quality Assessment of Observational Studies - Improving Antibiotic Prescribing f...Quality Assessment of Observational Studies - Improving Antibiotic Prescribing for Uncomplicated Acute Respiratory Tract Infections
- Risk-of-Bias Tables - Interventions for the Prevention of Posttraumatic Stress D...Risk-of-Bias Tables - Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological Trauma
- Preface - Methods for Insulin Delivery and Glucose Monitoring: Comparative Effec...Preface - Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness
- List of Excluded Studies - Safety of Vaccines Used for Routine Immunization in t...List of Excluded Studies - Safety of Vaccines Used for Routine Immunization in the United States: An Update
Your browsing activity is empty.
Activity recording is turned off.
See more...